Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENSET - GENXY -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (107)	11/3/2000 3:36:12 AM
From: nigel bates	Read Replies (1) \| Respond to of 200

There not being a current Annual Report 20-F on file at Edgar You're just spoiled by US disclosure rules (g). There are a couple of websites though... genxy.com gensetoligos.com I share your pain on the sharprice, though. nig

To: keokalani'nui who wrote (107)	11/3/2000 3:54:42 AM
From: nigel bates	Respond to of 200

"...The change in total revenues for the third quarter reflects the Company's shift in strategy away from entering into limited gene target discovery deals on behalf of pharmaceutical companies to a focus on developing products for its own benefit. As a result, research and development ("R&D") revenues decreased 42.7% to 2.9 million ($2.5 million), accounting for 46% of total revenues, while oligonucleotide sales increased 58.2% to 3.4 million ($3.0 million)...."